As a protease inhibitor, it has been suggested that SLPI provides protection to the mucosa and skin against the enzymatic pathways that lead to cancer invasion and progression by preventing tissue degradation from certain tumor proteases [9, 10]. This evidence concerns the gene SLPI and neoplasm.